EXOZ:NASDAQeXoZymes Inc. Analysis
Data as of 2026-09-27 - not real-time
$6.25
Latest Price
9/10Risk
Risk Level: High
Executive Summary
eXoZymes, Inc. is priced at $6.25, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have gained 4.1%. RSI sits at 47.6, which reads as neutral, and MACD momentum is bearish. The recent range runs from support at $6.00 up to resistance at $7.38.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 66.2%, a beta of 1.07 and a maximum drawdown of 73.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on sell — conviction 4 out of 10.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 66.2%, a beta of 1.07 and a maximum drawdown of 73.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on sell — conviction 4 out of 10.
Top Market Events
Program expected to commence in Q4 2026 and establish a roadmap for larger-scale production in 2027 LOS ANGELES, CA /...Seeking Alpha1moneXoZymes, Inc. EXOZ Q2 2026 Earnings Call TranscriptEverything in this presentation, other than...Yahoo Finance1moneXoZymes Inc. EXOZ Q2 FY2026 earnings call transcripteXoZymes reported a disciplined cash position of...
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Trading below the 200-day average of 8.66
- MACD momentum is negative
- 30-day volatility of 66.2%
Medium Term
1–3 yearsCautious
Model confidence: 4/10
Key Factors
- Trading below the 200-day average of 8.66
- 30-day volatility of 66.2%
- MACD momentum is negative
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Negative return on equity of -187.2%
- Negative free cash flow
- 30-day volatility of 66.2%
Key Metrics & Analysis
Financial Health
ROE-187.16%
ROA-74.74%
Debt/Equity29.69
P/B Ratio15.9
Op. Cash Flow$-6995227
Free Cash Flow$-3252423
Industry P/E30.5
Technical Analysis
TrendNeutral
RSI47.6
Support$6.00
Resistance$7.38
MA 20$6.44
MA 50$5.97
MA 200$8.66
MACDBearish
VolumeIncreasing
Fear & Greed Index94.88
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.07
Volatility66.24%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.